Scientists test 'Cancer-Killing Virus' for tough brain tumors
NCT ID NCT07472790
Summary
This early-stage study is testing a new two-part treatment for aggressive brain cancer that has come back after standard therapy. It combines a specially engineered virus designed to infect and kill cancer cells with a drug that helps the immune system attack the tumor. The main goals are to see if this approach is safe and if it can help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sanbo Brain Hospital, Capital Medical University
Beijing, Chaoyang District, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.